CLINICAL_TRIALS
research
· 2026-01-16
Clinical Trial Update: A Phase 4 Study to Evaluate the Effectiveness and Safety of Siltartoxatug Injection for Tetanus Prophylaxis Following Injury
Summary
Phase 4 clinical trial evaluating the effectiveness and safety of Siltartoxatug Injection for tetanus prophylaxis after injury; study status is not yet recruiti…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zhuhai Trinomab Pharmaceutical Co., Ltd. | Conditions: Tetanus | Status: NOT_YET_RECRUITING